Lincoln National Corp Has $1.46 Million Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Lincoln National Corp boosted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 55,761 shares of the pharmacy operator’s stock after buying an additional 1,726 shares during the period. Lincoln National Corp’s holdings in Walgreens Boots Alliance were worth $1,456,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the company. New York Life Investment Management LLC grew its stake in shares of Walgreens Boots Alliance by 0.4% in the 3rd quarter. New York Life Investment Management LLC now owns 114,506 shares of the pharmacy operator’s stock valued at $2,547,000 after buying an additional 499 shares during the period. Fulton Bank N.A. increased its holdings in shares of Walgreens Boots Alliance by 0.5% during the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock valued at $2,796,000 after acquiring an additional 523 shares in the last quarter. Insight Folios Inc raised its position in shares of Walgreens Boots Alliance by 5.8% during the fourth quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock worth $252,000 after purchasing an additional 525 shares during the period. Pinnacle Financial Partners Inc lifted its holdings in shares of Walgreens Boots Alliance by 4.9% in the 4th quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock worth $310,000 after purchasing an additional 555 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV grew its position in Walgreens Boots Alliance by 20.6% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 3,524 shares of the pharmacy operator’s stock valued at $92,000 after purchasing an additional 602 shares during the period. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 0.7 %

Shares of NASDAQ:WBA opened at $17.23 on Thursday. The stock has a market capitalization of $14.86 billion, a P/E ratio of -2.46, a price-to-earnings-growth ratio of 1.10 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a 12-month low of $17.21 and a 12-month high of $32.89. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The stock’s 50-day moving average price is $19.43 and its 200-day moving average price is $21.53.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm’s revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the business posted $1.16 EPS. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.80%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s payout ratio is -14.29%.

Insider Activity at Walgreens Boots Alliance

In other news, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The stock was acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares in the company, valued at $54,150. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

WBA has been the topic of several recent research reports. Bank of America dropped their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research report on Tuesday, March 26th. Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Morgan Stanley decreased their price target on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a report on Monday, April 1st. UBS Group dropped their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 3rd. Finally, TD Cowen reduced their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday, April 3rd. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.